Patents Assigned to Mor-Research Application Ltd.
  • Human immunomodulatory monoclonal antibodies for the treatment of cancer
    Patent number: 7524498
    Abstract: The present invention provides to a humanized monoclonal antibody having immunostimulatory effects. This antibody binds specifically to B lymphoblastoid cells, induces proliferation and activation of peripheral blood lymphocytes, particularly T cells, and is capable of eliciting an anti-tumor effect upon administration to subjects suffering from cancer.
    Type: Grant
    Filed: September 12, 2007
    Date of Patent: April 28, 2009
    Assignees: CureTech Ltd., Mor-Research Application Ltd.
    Inventors: Britta Hardy, Steven Tarran Jones, Leah Klapper